Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients
Ming Y Lim, Katarzyna JamiesonDepartment of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, USAAbstract: Acute myeloid leukemia (AML) is a hematopoietic stem cell disorder that affects approximately 14,000 persons each year in the US. AML occurs at all ages...
Guardado en:
Autores principales: | Lim MY, Jamieson K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aed040d05b6540809c2b6a817728bb87 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin
por: Hien K Duong, et al.
Publicado: (2009) -
Neuroautonomic evaluation of patients with unexplained syncope: incidence of complex neurally mediated diagnoses in the elderly
por: Rafanelli M, et al.
Publicado: (2014) -
Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia
por: Seiter K, et al.
Publicado: (2015) -
Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron M, et al.
Publicado: (2017) -
Review of the treatment of acute coronary syndrome in elderly patients
por: Maan Jokhadar, et al.
Publicado: (2009)